Nothing is guaranteed. In fact, we’re all up against some pretty tough odds to get where we are—to exist, to survive, to thrive. And when it comes to our health, we definitely can’t control the hand we’re dealt. But we only get one life. We only get one body. And every body deserves a shot at good health, so we need to fight for it. See how our Team USA partner athletes are fighting the odds to reach their goals: https://e.lilly/3YdLw4f #WeAreLilly This is a paid partnership between Lilly and Suni Lee.
Eli Lilly and Company
Pharmaceutical Manufacturing
Indianapolis, Indiana 1,831,050 followers
About us
We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.
- Website
-
http://www.lilly.com/
External link for Eli Lilly and Company
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Indianapolis, Indiana
- Type
- Public Company
- Specialties
- Pharmaceutical Development, Pharmaceuticals, Biotech, and Biopharmaceuticals
Locations
-
Primary
Lilly Corporate Center
Indianapolis, Indiana 46285, US
Employees at Eli Lilly and Company
Updates
-
The pandemic taught us to work differently. Now, on the other side, we're realizing some changes were for the better. One of the best examples of this? Our approach to clinical trials during the pandemic. From mobile recruiting efforts to telemedicine visits to direct shipping of investigational products, COVID-19 showed the incredible benefits these innovations can unlock. Now, we’re pushing to modernize clinical trials so we can effectively reach people where they live, making them easier, more equitable and encouraging more diverse participation. Learn more about what our clinical capabilities expert Janelle Sabo thinks should happen from here: https://lnkd.in/gXpNtRcY #WeAreLilly
-
People living with communicable diseases like HIV and TB are more likely to develop chronic diseases like diabetes, hypertension or cardiovascular disease. In low- to middle-income countries, health workers have made progress in early detection and access to medicines. But there’s more work to be done. That’s why we’re financially supporting REACH’s efforts to integrate TB and chronic disease care in Chennai, India, and joining forces with the NCD Alliance to call for wider implementation of integrated care models around the world. These models provide comprehensive, holistic and patient-centered care that improves public health and quality of life. #WeAreLilly
NCD Alliance on LinkedIn: #hiv #aids2024 #leadonncds #actonncds
linkedin.com
-
The impact of our medicines is felt in every corner of the globe. But our heart is rooted in our Indiana hometown. We’re grateful to IBJ Media for recognizing our leadership—including CEO Dave Ricks, CFO Anat Ashkenazi and Lilly USA President Patrik Jonsson—in this year’s #Indiana250 list of business influencers. #WeAreLilly
IBJ Media on LinkedIn: #indiana250
linkedin.com
-
How can we make sure medicines work safely in diverse patient populations around the world? By designing clinical trials to include diverse representation from the outset. To do so, we need clinical trial regulations to keep pace with the innovations that are allowing more community-based trial options. As our own Jeffrey Francer and Rob Metcalf explain in a recent STAT op-ed, the FDA, drug developers and investigators need to collaborate to make clinical trials more accessible for everyone. #WeAreLilly
Expand community-based research to make clinical trials more diverse
https://www.statnews.com
-
Can you tell the difference between a genuine Lilly medicine and a counterfeit product? As growing numbers of fake diabetes and obesity products are being advertised, we want to help you identify potential counterfeit products being marketed as Lilly medicine. Learn more: https://e.lilly/3S7D2YP
-
-
Our Team USA athletes may not have taken the same journey to get here, but the same possibility stands before them now: a medal in hand. Congratulations to all our partner athletes who are officially headed to Paris! Find out who’s part of our team here: https://e.lilly/4f252a8 #WeAreLilly
-
-
Breaking News: The FDA approved a new amyloid-targeting therapy to treat adults with early symptomatic #AlzheimersDisease. Learn more: https://e.lilly/4bsaOPk
-
Your skin color shouldn’t stand in the way of a proper diagnosis. There’s a gap in care for people with skin of color in dermatology. See what we’re doing to change that: https://e.lilly/4cu9M60 #eczema #WeAreLilly
-
-
How can we harness the promise of artificial intelligence to save real lives? Through our collaboration with OpenAI, we can use AI to invent new medicines for infections that are resistant to antimicrobial drugs—one of the biggest threats to human health globally. Read more: https://e.lilly/3VH6KF3 #WeAreLilly